Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Pharmacokinetic Evaluation of Zika Virus Immune Globulin in Healthy Volunteers

NCT03624946 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT03624946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03624946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Pharmacokinetic Evaluation of Zika Virus Immune Globulin in Healthy Volunteers
Lead sponsor
Emergent BioSolutions
Phase
Phase 1
Overall status
Completed
Start date
June 27, 2018
Completion date
March 6, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

zika virus disease, zika virus infection